Latest Innovation News

Aroa Biosurgery has reported a robust 23% revenue increase in FY25, achieving profitability and positive cash flow, setting the stage for continued growth in FY26.

Noxopharm has secured ethics approval to commence the HERACLES trial, marking the first human study of its novel SOF-SKN™ drug aimed at chronic inflammatory diseases.

Gentrack Group has committed an additional AUD4.5 million to Amber’s AUD45 million funding round, reinforcing their strategic partnership to accelerate the global rollout of smart energy technologies.

ikeGPS Group Limited (IKE) reported a robust FY25 with 19% revenue growth driven by subscription gains and improved margins, setting the stage for EBITDA break-even in FY26 H2 amid strong North American market demand.

ikeGPS Group Limited reported a robust 48% growth in annual subscription revenue exit run rate for FY25, alongside improved margins and a narrowed EBITDA loss. Despite a lucrative NZ$1 per share acquisition approach, the company declined the offer, confident in its growth trajectory.

Top Shelf International Holdings has resolved its long-standing excise debt issue, leading to the dismissal of Australian Taxation Office proceedings against its subsidiary.

Talius Group Limited has secured shareholder approval to consolidate its shares on a 10-for-1 basis, aiming to better align its capital structure with industry peers. The move affects all ordinary shares and performance rights, effective June 4, 2025.

Avecho Biotechnology has received $1.66 million from the Australian Government’s R&D Tax Incentive, reinforcing its commitment to a pivotal Phase III trial for its CBD-based insomnia treatment and accelerating its commercial ambitions.

American Rare Earths has installed groundwater monitoring wells at its Cowboy State Mine, advancing environmental permitting and keeping its rare earth project on track for 2029 production.

ReNerve Limited has gained marketing approval for its NervAlign® Nerve Cuff™ in Bahrain, marking its first regulatory success in the Middle East and opening access to a rapidly expanding regional market.

Epsilon Healthcare has emerged from Administration, securing expanded medicinal cannabis manufacturing permits and launching a new pharmacy brand as part of a strategic turnaround and growth plan.

INOVIQ Limited clarifies recent share price movements, confirming no undisclosed material information while highlighting an imminent ASCO presentation and provisional patent application tied to its EXO-OC ovarian cancer test.